awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37686529-234F7FFA-1472-4BF9-A929-F7E410CBF616
Q37686529-234F7FFA-1472-4BF9-A929-F7E410CBF616
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37686529-234F7FFA-1472-4BF9-A929-F7E410CBF616
Tyrosine kinase inhibitors to treat liver cancer.
P2860
Q37686529-234F7FFA-1472-4BF9-A929-F7E410CBF616
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37686529-234F7FFA-1472-4BF9-A929-F7E410CBF616
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
622b6ea40bf26aa6790cc59611f2346e48d0d0e9
P2860
Phase III trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment of patients with metastatic colorectal cancer: HORIZON III.